GSK-112640

Study Sponsor: GSK

Study Title

Immunogenicity, safety and reactogenicity of GlaxoSmithKline Biologicals’ pneumococcal vaccine GSK1024850A following primary and booster vaccination of healthy Japanese children

Medicine or Vaccine (generic name)

Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)

Sponsor Identification Number

112640

Trial Registry Identification Number(#'s)

NCT01027845 2011-003710-16

Medical Condition

Infections, Streptococcal

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=112640

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01027845

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2011-003710-16

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This is a follow-up study to 105553. An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

February 2015